Complete BRTX Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
BRTX DCF Analysis
BRTX (BioRestorative Therapies, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
| Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $119.8K | $145.8K | $401.0K | $501.3K | $626.6K | $783.2K | $979.0K | $1.2M |
| Revenue Growth % | - | 21.7% | 175.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| EBIT | $-19.0M | $-15.2M | $-11.6M | $25.1K | $31.3K | $39.2K | $49.0K | $61.2K |
| EBIT Margin % | -15838.1% | -10439.5% | -2881.6% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
| Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| NOPAT | $-14.2M | $-11.4M | $-8.7M | $18.8K | $23.5K | $29.4K | $36.7K | $45.9K |
| NOPAT Margin % | -11878.6% | -7829.6% | -2161.2% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
| Capex | $440.2K | $171.0K | $106.2K | $5.0K | $6.3K | $7.8K | $9.8K | $12.2K |
| Capex / Revenue % | 367.5% | 117.3% | 26.5% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
| Depreciation | $120.5K | $165.7K | $189.1K | $436.8K | $546.0K | $682.5K | $853.2K | $1.1M |
| D&A / Revenue % | 100.6% | 113.7% | 47.1% | 87.1% | 87.1% | 87.1% | 87.1% | 87.1% |
| Change in NWC | $-12.0M | $-363.3K | $-1.4M | $0 | $0 | $0 | $0 | $0 |
| NWC Change / Revenue % | -9981.3% | -249.2% | -346.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Unlevered FCF | $-2.6M | $-11.1M | $-7.2M | $450.6K | $563.3K | $704.1K | $880.1K | $1.1M |
| UFCF % Chg. | - | -326.5% | 34.9% | 106.3% | 25.0% | 25.0% | 25.0% | 25.0% |
| FCF / Revenue % | -2164.1% | -7584.1% | -1794.6% | 89.9% | 89.9% | 89.9% | 89.9% | 89.9% |
| Discount Factor | - | - | - | 0.943 | 0.890 | 0.839 | 0.792 | 0.747 |
| Present Value of FCF | - | - | - | $425.0K | $501.1K | $590.8K | $696.6K | $821.3K |
| Sum of PV of UFCF | - | - | - | $425.0K | $926.1K | $1.5M | $2.2M | $3.0M |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
| WACC Calculation | Value |
|---|---|
| Cost of Debt | 7.0% |
| Tax Rate | 25.0% |
| After Tax Cost of Debt | 5.2% |
| Risk Free Rate | 4.46% |
| Market Risk Premium | 4.3% |
| Beta | 0.36 |
| Cost of Equity | 6.0% |
| Total Debt | $0 |
| Market Cap | $13.5M |
| Total Capital | $13.5M |
| Debt Weighting | 0.0% |
| Equity Weighting | 100.0% |
| WACC | 6.0% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
| Terminal Value Calculation | Value |
|---|---|
| Terminal Growth Rate | 2.5% |
| Final Year FCF | $1.1M |
| Terminal Value | $32.0M |
| PV of Terminal Value | $23.9M |
| Cumulative PV of UFCF | $3.0M |
| Net Debt | $-547.9K |
| Equity Value | $27.5M |
| Shares Outstanding | 7.8M |
| Implied Share Price | $4 |
| Current Share Price | $2 |
| Implied Upside/(Downside) | +96.8% |
Valuation Summary
$3.54
Implied Price
$1.80
Current Price
+96.8%
Upside/Downside
6.0%
WACC
BRTX Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-14.00
-878.0%
Peer Median: 9.7x
EV/EBITDA
$0.00
-100.0%
Peer Median: 1.2x
P/S Ratio
$0.02
-98.7%
Peer Median: 0.4x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for BRTX's business model and current situation.
Multiple Comparison
| Multiple | BRTX Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -1.2x | 9.7x | 5.3x | -112.9% | Undervalued |
| EV/EBITDA | Infinityx | 1.2x | 1.2x | Infinity% | Overvalued |
| P/S Ratio | 34.5x | 0.4x | 5.1x | 7784.6% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 1.0x | 1.2x | 0.2x | |
| $0.01B | 0.0x | 0.0x | 0.4x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 9.7x | -18.0x | 31.6x | |
| $0.01B | 0.0x | 0.0x | 34.5x | |
| $0.01B | 0.0x | 0.0x | 36.1x | |
| $0.01B | 0.0x | 0.0x | 14.8x | |
| $0.01B | 0.0x | 0.0x | 0.0x |